tiprankstipranks
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market
VVOS
Vivos Therapeutics
RESEARCH TOOLSreports
Want to see VVOS full AI Analyst Report?

Vivos Therapeutics (VVOS) Income Statement

231 Followers

Vivos Therapeutics Income Statement

Last quarter (Q4 2025), Vivos Therapeutics's total revenue was $3.82M, an increase of 26.79% from the same quarter last year. In Q4, Vivos Therapeutics's net income was $-6.95M. See Vivos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Dec 22Mar 22
Total Revenue
$ 17.44M$ 15.03M$ 13.80M$ 16.02M$ 16.89M
Gross Profit
$ 10.54M$ 9.02M$ 8.27M$ 10.02M$ 12.60M
Operating Expenses
$ 30.44M$ 20.19M$ 25.57M$ 35.05M$ 32.08M
Depreciation and Amortization
$ 1.31M$ 581.00K$ 621.00K$ 669.00K$ 733.00K
EBITDA
$ -18.59M$ -10.59M$ -16.68M$ -24.36M$ -19.54M
Operating Income
$ -19.89M$ -11.17M$ -17.30M$ -25.03M$ -19.47M
Other Income/Expenses
$ -1.34M$ 35.00K$ 3.71M$ 1.19M$ -817.00K
Pretax Income
$ -21.23M$ -11.14M$ -13.58M$ -23.84M$ -20.29M
Net Income
$ -21.23M$ -11.14M$ -13.58M$ -23.84M$ -20.29M
Per Share Metrics
Basic EPS
$ -2.06$ -2.22$ -11.14$ -25.90$ -23.89
Diluted EPS
$ -2.06$ -2.22$ -11.14$ -25.90$ -23.89
Weighted Average Shares Outstanding
 10.27M 5.02M 1.22M 920.48K 849.32K
Weighted Average Shares Outstanding (Diluted)
 10.27M 5.02M 1.22M 920.48K 849.32K
Currency in USD

Vivos Therapeutics Earnings and Revenue History